| Q42199407 | A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat. |
| Q71585396 | A phase II trial of doxorubicin HCl Liposome Injection in patients with advanced pancreatic adenocarcinoma |
| Q72280945 | A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo |
| Q26773160 | Advances and Challenges of Liposome Assisted Drug Delivery |
| Q48233894 | Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study |
| Q36135564 | An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation |
| Q69173245 | Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin |
| Q39734481 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties |
| Q37059896 | Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation |
| Q69988384 | Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes |
| Q54985807 | Antitumor effect of liposome-entrapped adriamycin administered via the portal vein. |
| Q37993466 | Challenges in development of targeted liposomal therapeutics |
| Q68792263 | Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes |
| Q92343750 | Development of Liposomal Gemcitabine with High Drug Loading Capacity |
| Q57610519 | Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse |
| Q41378026 | Diversity of lipid-based polyene formulations and their behavior in biological systems |
| Q67902977 | Encapsulation of doxorubicin in thermosensitive small unilamellar vesicle liposomes |
| Q68514006 | Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice |
| Q36584869 | Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery. |
| Q54941595 | Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. |
| Q46149999 | In vitro and in vivo studies evaluating a liposome system for drug solubilization |
| Q37639117 | In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit |
| Q36334145 | Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma |
| Q39661451 | Liposomes as carriers of antimicrobial agents |
| Q40385547 | Liposomes as carriers of cancer chemotherapy. Current status and future prospects |
| Q68362166 | Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution |
| Q40485546 | Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential |
| Q28706344 | Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics |
| Q38928086 | Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages |
| Q39673726 | Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. |
| Q48350433 | Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles |
| Q43065300 | Pegylated liposomal doxorubicin in ovarian cancer |
| Q69688098 | Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II) |
| Q36115992 | Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice |
| Q42883191 | Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting |
| Q48166834 | Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy |
| Q57117439 | Stability of liposomes on storage: freeze dried, frozen or as an aqueous dispersion |
| Q68611343 | Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes |
| Q35992199 | Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model |
| Q78115783 | Synthesis of a novel lipopeptide with alpha-melanocyte-stimulating hormone peptide ligand and its effect on liposome stability |
| Q41728456 | The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases |
| Q46763113 | Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma |
| Q52248411 | Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes. |
| Q72459435 | Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice |